| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.7B | $0.6B | $0.5B | $0.4B | $0.3B | $0.2B | $0.1B | $0.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $1.77 | $1.79 | $1.70 | $1.84 | $1.79 | $1.76 | $0.53 | $0.38 |
| EPS (Diluted) | $1.77 | $1.78 | $1.70 | $1.83 | $1.78 | $1.74 | $0.52 | $0.37 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.8B | $8.5B | $7.8B | $6.7B | $5.2B | $3.9B | $2.7B | $2.0B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B |
| Total Liabilities | $3.5B | $3.0B | $2.6B | $2.1B | $1.8B | $1.4B | $1.0B | $0.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $6.3B | $5.5B | $5.2B | $4.6B | $3.4B | $2.5B | $1.7B | $1.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $0.4B | $0.4B | $0.4B | $0.2B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-1.5B | $-0.9B | $-1.3B | $-1.6B | $-1.4B | $-1.3B | $-0.7B | $-0.6B |
| Capital Expenditures | — | $0.9B | $1.2B | $1.6B | $1.4B | $1.3B | $0.7B | — |
| Financing Cash Flow | $1.1B | $0.4B | $0.9B | $1.2B | $1.2B | $1.1B | $0.5B | $0.5B |